


| Salt Composition: | Mirabegron (50mg) |
| Manufacturer: | Fibovil Pharmaceuticals Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Mirahype 50mg Tablet ER is used to treat symptoms of overactive bladder, including increased or frequent urination, urgent need to urinate, and inability to control urination. Mirahype 50mg Tablet ER is advised to take it in a dose and duration as per prescription. It can be taken with or without food. Swallow the medicine as a whole without crushing or chewing it. You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms. The course of the treatment should be completed for better efficacy of the medicine. Some common side effects of this medicine are constipation, headache, high blood pressure, nasal inflammation, urinary tract infection, rapid heartbeat, and joint pain. If any of the side effects bother you or persist, consult the doctor without delay.
Mirahype 50mg Tablet ER is a beta 3-receptor agonist. It works by activating the receptor in the bladder causing the bladder muscles to relax. It prevents frequent, urgent or uncontrolled urination.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mirahype 50mg Tablet ER may be taken with or without food but it is better to take it at a fixed time.
Alcohol
Caution is advised when consuming alcohol with Mirahype 50mg Tablet ER. Please consult your doctor.
Breastfeed
Mirahype 50mg Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Mirahype 50mg Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.